{
    "Trade/Device Name(s)": [
        "FIA Blood Glucose Monitoring System (G2)"
    ],
    "Submitter Information": "HMD BioMedical Inc.",
    "510(k) Number": "K131173",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120064",
        "K032985"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX",
        "JQP"
    ],
    "Summary Letter Date": "October 2, 2014",
    "Summary Letter Received Date": "September 8, 2014",
    "Submission Date": "September 5, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FIA Blood Glucose Meter (G2)"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution",
        "Check Strip"
    ],
    "Document Summary": "FDA 510(k) summary for FIA Blood Glucose Monitoring System (G2), an electrochemical biosensor for quantitative measurement of glucose in fresh capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips for self-testing by people with diabetes at home; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}